Literature DB >> 23019386

Amyotrophic lateral sclerosis: update and new developments.

Ashley J Pratt1, Elizabeth D Getzoff, J Jefferson P Perry.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. It is typically characterized by adult-onset degeneration of the upper and lower motor neurons, and is usually fatal within a few years of onset. A subset of ALS patients has an inherited form of the disease, and a few of the known mutant genes identified in familial cases have also been found in sporadic forms of ALS. Precisely how the diverse ALS-linked gene products dictate the course of the disease, resulting in compromised voluntary muscular ability, is not entirely known. This review addresses the major advances that are being made in our understanding of the molecular mechanisms giving rise to the disease, which may eventually translate into new treatment options.

Entities:  

Year:  2012        PMID: 23019386      PMCID: PMC3457793          DOI: 10.2147/DNND.S19803

Source DB:  PubMed          Journal:  Degener Neurol Neuromuscul Dis        ISSN: 1179-9900


  178 in total

1.  Do twin studies still have anything to teach us about the genetics of amyotrophic lateral sclerosis?

Authors:  Kevin Talbot
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-12       Impact factor: 10.154

2.  Metabolomic analysis and signatures in motor neuron disease.

Authors:  Steve Rozen; Merit E Cudkowicz; Mikhail Bogdanov; Wayne R Matson; Bruce S Kristal; Chris Beecher; Scott Harrison; Paul Vouros; Jimmy Flarakos; Karen Vigneau-Callahan; Theodore D Matson; Kristyn M Newhall; M Flint Beal; Robert H Brown; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2005       Impact factor: 4.290

3.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Authors:  Cédric Raoul; Toufik Abbas-Terki; Jean-Charles Bensadoun; Sandrine Guillot; Georg Haase; Jolanta Szulc; Christopher E Henderson; Patrick Aebischer
Journal:  Nat Med       Date:  2005-03-13       Impact factor: 53.440

4.  Dominant expression of angiogenin in NeuN positive cells in the focal ischemic rat brain.

Authors:  Li Huang; Yining Huang; Huailian Guo
Journal:  J Neurol Sci       Date:  2009-08-08       Impact factor: 3.181

5.  Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation.

Authors:  S Kato; H Sumi-Akamaru; H Fujimura; S Sakoda; M Kato; A Hirano; M Takikawa; E Ohama
Journal:  Acta Neuropathol       Date:  2001-09       Impact factor: 17.088

6.  Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.

Authors:  Jiou Wang; George W Farr; Caroline J Zeiss; Diego J Rodriguez-Gil; Jean H Wilson; Krystyna Furtak; D Thomas Rutkowski; Randal J Kaufman; Cristian I Ruse; John R Yates; Steve Perrin; Mel B Feany; Arthur L Horwich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

7.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Control of motoneuron survival by angiogenin.

Authors:  Dairín Kieran; Jordi Sebastia; Matthew J Greenway; Matthew A King; Dervla Connaughton; Caoimhin G Concannon; Beau Fenner; Orla Hardiman; Jochen H M Prehn
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

9.  Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.

Authors:  Guozhi Zhu; Chuan-Jin Wu; Yongge Zhao; Jonathan D Ashwell
Journal:  Curr Biol       Date:  2007-08-21       Impact factor: 10.834

10.  CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees.

Authors:  P Andreas Jonsson; Asa Bäckstrand; Peter M Andersen; Johan Jacobsson; Matthew Parton; Chris Shaw; Robert Swingler; Pamela J Shaw; Wim Robberecht; Albert C Ludolph; Teepu Siddique; Veronica I Skvortsova; Stefan L Marklund
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

View more
  34 in total

Review 1.  Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis.

Authors:  Anna Tury; Kristine Tolentino; Yimin Zou
Journal:  Dev Neurobiol       Date:  2014-01-22       Impact factor: 3.964

2.  RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.

Authors:  Nadine Bakkar; Arianna Kousari; Tina Kovalik; Yang Li; Robert Bowser
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

3.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes.

Authors:  Ashley J Pratt; David S Shin; Gregory E Merz; Robert P Rambo; W Andrew Lancaster; Kevin N Dyer; Peter P Borbat; Farris L Poole; Michael W W Adams; Jack H Freed; Brian R Crane; John A Tainer; Elizabeth D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

4.  Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.

Authors:  Hisham Qosa; Jessica Lichter; Mark Sarlo; Shashirekha S Markandaiah; Kevin McAvoy; Jean-Philippe Richard; Michael R Jablonski; Nicholas J Maragakis; Piera Pasinelli; Davide Trotti
Journal:  Glia       Date:  2016-05-09       Impact factor: 7.452

5.  Copper-based pulsed dipolar ESR spectroscopy as a probe of protein conformation linked to disease states.

Authors:  Gregory E Merz; Peter P Borbat; Ashley J Pratt; Elizabeth D Getzoff; Jack H Freed; Brian R Crane
Journal:  Biophys J       Date:  2014-10-07       Impact factor: 4.033

6.  Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Stephanie Navarro; Tony E Besong; Kayla J Boccio; Surafuale Hailu; Mohammed Khatib; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Exp Neurol       Date:  2018-08-30       Impact factor: 5.330

Review 7.  EWSR1, a multifunctional protein, regulates cellular function and aging via genetic and epigenetic pathways.

Authors:  Junghee Lee; Phuong T Nguyen; Hyun Soo Shim; Seung Jae Hyeon; Hyeonjoo Im; Mi-Hyun Choi; Sooyoung Chung; Neil W Kowall; Sean Bong Lee; Hoon Ryu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-24       Impact factor: 5.187

Review 8.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

Review 9.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

10.  Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.

Authors:  Aparna Sharma; Anu Mary Varghese; Kalyan Vijaylakshmi; Rajendrarao Sumitha; V K Prasanna; S Shruthi; B K Chandrasekhar Sagar; Keshava K Datta; Harsha Gowda; Atchayaram Nalini; Phalguni Anand Alladi; Rita Christopher; Talakad N Sathyaprabha; Trichur R Raju; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.